Department of Supportive Care Medicine, Moffitt Cancer Center, and.
Department of Oncologic Sciences, University of South Florida, Tampa, Florida.
J Natl Compr Canc Netw. 2019 Sep 1;17(9):1059-1064. doi: 10.6004/jnccn.2019.7301.
Information about the frequency of cannabinoid use and the clinical characteristics of its users in oncology supportive care is limited. This study explored associations between cannabinoid use and cancer-related clinical characteristics in a cancer population.
This retrospective review included 332 patients who had a urine drug test (UDT) for tetrahydrocannabinol (THC) together with completion of an Edmonton Symptom Assessment Scale (ESAS) and cannabinoid history questionnaire on the same day that urine was obtained during 1 year in the supportive care clinic.
The frequency of positive results for THC in a UDT was 22.9% (n=76). Significant statistical differences were seen between THC-positive and THC-negative patients for age (median of 52 [lower quartile, 44; upper quartile, 56] vs 58 [48; 67] years; P<.001), male sex (53.9% vs 39.5%; P=.034), and past or current cannabinoid use (65.8% vs 26.2%; P<.001). Statistical significance was observed in ESAS items between the THC-positive and THC-negative groups for pain (7 [lower quartile, 5; upper quartile; 8] vs 5 [3; 7]; P=.001), nausea (1 [0; 3] vs 0 [0; 3]; P=.049), appetite (4 [2; 7] vs 3 [0; 5.75]; P=.015), overall well-being (5.5 [4; 7] vs 5 [3; 6]; P=.002), spiritual well-being (5 [2; 6] vs 3 [1; 3]; P=.015), insomnia (7 [5; 9] vs 4 [2; 7]; P<.001), and total ESAS (52 [34; 66] vs 44 [29; 54]; P=.001). Among patients who reported current or past cannabinoid use, THC-positive patients had higher total scores and scores for pain, appetite, overall well-being, spiritual well-being, and insomnia than THC-negative patients.
Patients with cancer receiving outpatient supportive care who had positive UDT results for THC had higher symptom severity scores for pain, nausea, appetite, overall and spiritual well-being, and insomnia compared with their THC-negative counterparts. These results highlight potential opportunities to improve palliative care.
有关癌症支持性护理中使用大麻素的频率和使用者的临床特征的信息有限。本研究探讨了癌症患者中使用大麻素与癌症相关临床特征之间的关联。
本回顾性研究纳入了 332 名在支持性护理诊所同一天进行尿液药物测试(THC 的 UDT)并完成了 Edmonton 症状评估量表(ESAS)和大麻素病史问卷的患者。
UDT 中 THC 阳性结果的频率为 22.9%(n=76)。THC 阳性和 THC 阴性患者在年龄(中位数 52 [下四分位数,44;上四分位数,56] vs 58 [48;67]岁;P<.001)、男性(53.9% vs 39.5%;P=.034)和过去或当前大麻素使用(65.8% vs 26.2%;P<.001)方面存在显著统计学差异。THC 阳性和 THC 阴性组在 ESAS 项目中观察到疼痛(7 [下四分位数,5;上四分位数;8] vs 5 [3;7];P=.001)、恶心(1 [0;3] vs 0 [0;3];P=.049)、食欲(4 [2;7] vs 3 [0;5.75];P=.015)、总体幸福感(5.5 [4;7] vs 5 [3;6];P=.002)、精神幸福感(5 [2;6] vs 3 [1;3];P=.015)、失眠(7 [5;9] vs 4 [2;7];P<.001)和总 ESAS(52 [34;66] vs 44 [29;54];P=.001)之间存在统计学意义。在报告当前或过去大麻素使用的患者中,THC 阳性患者的疼痛、食欲、总体幸福感、精神幸福感和失眠的总评分和评分均高于 THC 阴性患者。
接受门诊支持性护理的癌症患者,其 UDT 结果为 THC 阳性的患者与 THC 阴性患者相比,疼痛、恶心、食欲、总体和精神幸福感以及失眠的症状严重程度评分更高。这些结果突出了改善姑息治疗的潜在机会。